3 citations
,
October 2001 in “British Journal of Ophthalmology”
In this case, intralesional cidofovir showed a successful outcome for treating SCC without systemic toxicity, suggesting it may be worth considering alongside surgical excision.
This case report highlights the rare occurrence of overlapping syndromes including SLE, RA, and AAV in a patient with discoid lupus erythematosus, noting the persistent role of prior viral infection remains unclear.
2 citations
,
November 2025 in “Pharmacology Research & Perspectives”
This study analyzed post-marketing data from the U.S. FDA Adverse Event Reporting System and identified both known and new safety concerns for Avacopan, an anti-neutrophil cytoplasmic antibodies-associatedvasculitis treatment, emphasizing the need for monitoring during early treatment stages.
This study found that clinicians frequently prefer cyclophosphamide over rituximab for induction therapy of childhood-onset systemic lupus erythematosus and ANCA-associatedvasculitis, following a high-dose regimen recommended by the NIH.